在阿尔茨海默病和唐氏综合征细胞模型中的聚胺生物合成失调
Andres Sola1, Alex Sandberg2,3, Caitlin Pham2
1Department of Chemistry and Biochemistry, DU, Denver, CO 80208, USA.
bioRxiv : the preprint server for biology
|February 20, 2025
概括
多氨酸通过增加粉样β (Aβ42) 聚合,加剧了唐氏综合征 (DS) 中的阿尔茨海默病 (AD) 病理. 使用DFMO抑制甲素脱碳酶 (ODC) 降低了Aβ42和使AD相关蛋白质正常化,这表明DS-AD的治疗标.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 生物化学 生物化学
背景情况:
- 唐氏综合症 (DS) 个体通常会发展为早期发病的阿尔茨海默氏病 (AD).
- 在DS的21号染色体上的三倍基因与AD病理学有关.
- 聚胺通路失调与阿尔茨海默病有关,但其在DS-AD中的作用尚不清楚.
研究的目的:
- 调查多氨酸在DS相关AD的发病过程中的作用.
- 评估针对DS-AD中的聚胺途径的治疗潜力.
主要方法:
- 在小鼠和人类海马细胞和组织中分析了聚胺水平.
- 研究了ODC抑制剂二甲基诺尼丁 (DFMO) 对DS纤维细胞中Aβ42聚合和蛋白质表达的影响.
主要成果:
- 氨基酸β 42 (Aβ42) 通过小素脱酶 (ODC) 激活增加了多胺水平.
- 在DS纤维细胞中,DFMO治疗降低了Aβ42聚合和粉样蛋白前体蛋白 (APP) 水平.
- 在DS-AD海马组织中观察到高的聚胺水平和ODC/Aβ42同位素.
结论:
- 聚胺生物合成可能会在DS中恶化Aβ42毒性和APP表达,从而导致AD的进展.
- DFMO降低Aβ42聚合和恢复蛋白质平衡的能力突出显示了多胺途径作为DS-AD的治疗标.
相关概念视频
Alzheimer's Disease: Overview
429
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
429
Amyloid Fibrils
9.2K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.2K


